Cargando…
Primary prophylaxis of venous thromboembolic disease with direct oral anticoagulants in patients with severe inherited thrombophilia
Direct oral anticoagulants (DOACs) are widely used in several indications, but data on their efficacy and safety in individuals affected by severe inherited thrombophilia, yet without any personal history of thrombosis, is lacking. Severe inherited thrombophilia abnormalities, especially antithrombi...
Autores principales: | Krumb, Evelien, Hermans, Cedric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938623/ https://www.ncbi.nlm.nih.gov/pubmed/33733024 http://dx.doi.org/10.1002/rth2.12479 |
Ejemplares similares
-
Living with a “hemophilia‐free mind” – The new ambition of hemophilia care?
por: Krumb, Evelien, et al.
Publicado: (2021) -
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study
por: Campello, Elena, et al.
Publicado: (2020) -
Inherited Thrombophilia in the Era of Direct Oral Anticoagulants
por: Khider, Lina, et al.
Publicado: (2022) -
Venous thromboembolism in COVID-19 and inherited thrombophilia
por: Medina, Ester Martins Camillozzi, et al.
Publicado: (2022) -
A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing
por: Deloughery, Thomas G., et al.
Publicado: (2022)